CAS号:875337-44-3
品名:MGCD-265类似物MGCD-265analog
中文别名:N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-b]吡啶-7-氧基)苯基氨基硫代甲酰基)-2-苯乙酰胺;
英文别名:N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide;Benzeneacetamide,N-[[[3-fluoro-4-[[2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxy]phenyl]amino]thioxomethyl]-;N-[[3-fluoro-4-[2-(1-methylimidazol-4-yl)thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-phenylacetamide;MGCD-265-analog;MGCD265-analog;Glesatinib-analog;MGCD265-analog;
分子式:C26H20FN5O2S2
分子量:517.598
精确质量:517.104
Psa:151.93
EINECS号:812-647-3
外观与性状:白色至米黄色固体
密度:1.41g/cm3
沸点:195.7ºC at 760 mmHg
闪点:72.1ºC
折射率:1.707
简介:MGCD-265isanoveldualc-Met/VEGFR2receptortyrosinekinaseinhibitorpossessingfavorablepharmacokineticprofilesandshowedhighefficacyinvivoinseveralhumantumorxenograftmodelsinmice.
蛋白酪氨酸激酶